Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry

Chemical Research in Toxicology

Volumn 23, Issue 8, 2010, Pages 1313-1321

  Harrington, Chris F ^a,b   Le Pla, Rachel C ^a   Jones, George D D ^c   Thomas, Anne L ^c   Farmer, Peter B ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CISPLATIN; EPIRUBICIN; FLUOROURACIL; GUANINE;

ADD ON THERAPY; ADENOCARCINOMA; ARTICLE; ATOMIC EMISSION SPECTROMETRY; BLOOD SAMPLING; CALF (BOVINE); CANCER CELL; CANCER PATIENT; CYTOTOXICITY; DNA ADDUCT; DNA CROSS LINKING; DRUG DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LEUKOCYTE ROLLING; MULTIPLE CYCLE TREATMENT; THYMUS;

ANIMALS; ANTINEOPLASTIC AGENTS; CATTLE; CELL LINE, TUMOR; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CISPLATIN; DNA; DNA ADDUCTS; DNA, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; GUANINE; HUMANS; LEUKOCYTES; MASS SPECTROMETRY; SENSITIVITY AND SPECIFICITY;

EID: 77955692257     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx100023c     Document Type: Article

References (23)

1. Kelland, L. (2007) The resurgence of platinum-based cancer chemotherapy Nature Rev. Cancer 7, 573-584
2. Fink, D. and Howell, S. B. (2000) How does cisplatin kill cells? In Platinum-Based Drugs in Cancer Therapy (Kelland, L. R. and Farrell, N. P., Eds.) Humana Press, Totowa, NJ.
3. Saris, C. P., van de Vaart, P. J. M., Rietbroek, R. C., and Blommaert, F. A. (1996) In vitro formation of DNA adducts by cisplatin, lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cells Carcinogenesis 17, 2763-2769
4. Fichtinger-Schepman, A. J., Baan, R. A., Luiten-Schuite, A., Van Dijk, M., and Lohman, P. H. M. (1985) Immunochemical quantitation of adducts induced in DNA by cisdiammine-dichloroplatinum(II) and analysis of adduct-related DNAunwinding Chem.-Biol. Interact. 55, 275-288
5. Fichtinger-Schepman, A. J., van der Veer, J. L., den Hartog, J. H. J., Lohman, P. H. M., and Reedijk (1985) Adducts of the antitumour drug cis-diamminedichloroplatinum(II) with DNA-Formation, identification and quantitation Biochemistry 24, 707-713
6. Welters, M. J. P., Maliepaard, M., Jacobs-Bergmans, A. J., Baan, R. A., Schellens, J. H. M., Ma, J. G., van der Vijgh, W. J. F., Braakhuis, B. J. M., and Fichtinger-Schepman, A. M. J. (1997) Improved P-32 postlabelling assay for the quantification of the major platinum-DNA adducts Carcinogenesis 18, 1767-1774
7. Iijima, H., Patrzyc, H. B., Dawidzik, J. B., Budzinski, E. E., Cheng, H.-C., Freund, H. G., and Box, H. C. (2004) Measurement of DNA adducts in cells exposed to cisplatin Anal. Biochem. 333, 65-71
8. Harrington, C. F., Vidler, D. S., and Jenkins, R. O. (2010) Organometallics in Environment and Toxicology. In Metal Ions in Life Science (Sigel, A., Sigel, H., and Sigel, R. K. O., Eds.) Vol. 7, Royal Society of Chemistry, Cambridge, United Kingdom.
9. Baskerville-Abraham, I. M., Boysen, G., Troutman, J. M., Mutlu, E., Collins, L., de Krafft, K. E., Lin, W., King, C., Chaney, S. G., and Swenberg, J. A. (2009) Development of an ultraperformance liquid chromatography/mass spectrometry method to quantify cisplatin 1,2 intrastrand guanine-guanine adducts Chem. Res. Toxicol. 22, 905-912
10. 32P-Postlabelling assay for the quantification of the major platinum-DNA adducts Anal. Biochem. 275, 30-38
11. Brouwers, E. E. M., Tibben, M., Pluim, D., Rosing, H., Boot, H., Cats, A., Schellens, J. H. M., and Beijnen, J. H. (2008) Inductively coupled plasma mass spectrometric analysis of the total amount of platinum in DNA extracts from peripheral blood mononuclear cells and tissue from patients treated with cisplatin Anal. Bioanal. Chem. 391, 577-585
12. Brouwers, E. E. M., Tibben, M., Rosing, H., Schellens, J. H. M., and Beijnen, J. H. (2008) The application of inductively coupled plasma mass spectrometry in clinical and pharmacological oncology research Mass Spectrom. Rev. 27, 67-100
13. Tang, X., Hayes, J. W., Schroder, L., Cacini, W., Dorsey, J., Elder, R. C., and Tepperman, K. (1997) Determination of biotransformation products of platinum drugs in rat and human urine Met. Based Drugs 4, 97-109
14. Hann, S., Koellensperger, G., Stefanka, Z., Stingeder, G., Furhacker, M., Buchberger, W., and Mader, R. M. (2003) Application of HPLC-ICP-MS to speciation of cisplatin and its degradation products in water containing different chloride concentrations and in human urine J. Anal. At. Spectrom. 18, 1391-1395
15. Meczes, E. L., Azim-Araghi, A., Ottley, C. J., Pearson, D. G., and Tilby, M. J. (2005) Specific adducts recognised by a monoclonal antibody against cisplatin-modified DNA Biochem. Pharmacol. 70, 1717-1725
16. Sar, D. G., Montes-Bayon, M., Gonzalez, E. B., and Sanz-Medel, A. (2006) Speciation studies of cisplatin adducts with DNA nucleotides via elemental specific detection (P and Pt) using liquid chromatography-inductively coupled plasma mass spectrometry and structural characterization by electrospray mass spectrometry J. Anal. At. Spectrom. 21, 861-868
17. Bonetti, A., Apostoli, P., Zaninelli, M., Pavanel, F., Colombatti, M., Cetto, G. L., Franceschi, T., Sperotto, L., and Leone, R. (1996) Inductively coupled plasma mass spectrometry quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin-or carboplatin-based chemotherapy Clin. Cancer Res. 2, 1829-1835
18. Le Pla, R. C., Ritchie, K. J., Henderson, C. J., Wolf, C. R., Harrington, C. F., and Farmer, P. B. (2007) Development of a liquid chromatography- electrospray ionization tandem mass spectrometry method for detecting oxaliplatin-DNA intrastrand cross-links in biological samples Chem. Res. Toxicol. 20, 1177-1182
19. Hagemeister, T. and Linscheid, M. (2002) Mass spectrometry of cis-diamminedichloroplatinum(II) adducts with the dinucleosidemonophosphates d(ApG), d(GpG) and d(TpC) in an ion trap J. Mass Spectrom. 37, 731-747
20. Smith, C. J., Wilson, I. D., Abou-Shakra, F., Payne, R., Parry, T. C., Sinclair, P., and Roberts, D. W. (2003) A comparison of the quantitative methods for the analysis of the platinum-containing anticancer drug ZD0473 by HPLC coupled to either a triple quadrupole mass spectrometer or an inductively coupled plasma mass spectrometer Anal. Chem. 75, 1463-1469
21. Reed, E., Dabholkar, M., and Chabner, B. A. (1996) Platinum analogues. In Cancer Chemotherapy and Biotherapy, 2 nd ed. (Chabner, B. A. and Longo, D. L., Eds.) pp 357-378, Lippincott-Raven Pub., Philadelphia.
22. Wistuba, I. I., Bryant, D., Behrens, C., Milchgrub, S., Virmani, A. K., Ashfaq, R., Minna, J. D., and Gazdar, A. F. (1999) Comparison of features of human lung cancer cell lines and their corresponding tumours Clin. Cancer Res. 5, 991-1000
23. Sar, D. G., Montes-Bayon, M., Ortiz, L. A., Gonzalez, E. B., Sierra, L. M., and Sanz-Medel, A. (2008) In vivo detection of DNA adducts induced by cisplatin using capillary HPLC-ICP-MS and their correlation with genotoxic damage in Drosophila melanogaster Anal. Bioanal. Chem. 390, 37-44